PhaseBio Pharmaceuticals, Inc. (PHAS) Financials

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$0.07
Day's range
$0.09
$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80M-$100M-$100MEarning2016201620172017201820182019201920202020202120210%0%-10000%-10000%-20000%-20000%-30000%-30000%-40000%-40000%-50000%-50000%-60000%-60000%Profit Margin
Profit Margin
Revenue
Earnings

PHAS Income statement / Annual

Last year (2021), PhaseBio Pharmaceuticals, Inc.'s total revenue was $10.83 K, a decrease of 96.62% from the previous year. In 2021, PhaseBio Pharmaceuticals, Inc.'s net income was -$131.07 K. See PhaseBio Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $10.83 K $320.00 K $2.36 M $668.00 K $0.00 $0.00
Cost of Revenue $0.00 $319.68 K $0.00 $0.00 $0.00 $0.00
Gross Profit $10.83 K $320.00 $2.36 M $668.00 K $0.00 $0.00
Gross Profit Ratio 1 0 1 1 0 0
Research and Development Expenses $102.11 K $72.09 M $30.91 M $15.46 M $6.21 M $7.38 M
General & Administrative Expenses $16.09 K $13.09 M $11.19 M $4.86 M $2.33 M $2.13 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $16.09 K $13.09 M $11.19 M $4.86 M $2.33 M $2.13 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $118.19 K $85.18 M $42.10 M $20.31 M $8.54 M $9.50 M
Cost And Expenses $118.19 K $85.18 M $42.10 M $20.31 M $8.54 M $9.50 M
Interest Income $14.00 $237.00 K $1.58 M $387.00 K $52.00 K $29.00 K
Interest Expense -$947.00 $1.45 M $1.08 M $3.92 M $2.72 M $0.00
Depreciation & Amortization $1.79 M $508.00 K $174.00 K $105.00 K $96.00 K $92.00 K
EBITDA $1.66 M -$96.61 M -$38.00 M -$19.82 M -$7.43 M -$9.13 M
EBITDA Ratio 153.5 -301.91 -16.09 -29.67 0 0
Operating Income Ratio -12.04 -265.18 -16.83 -29.41 0 0
Total Other Income/Expenses Net $947.00 -$13.71 M $489.00 K -$4.20 M -$1.71 M $281.00 K
Income Before Tax -$129.47 K -$98.57 M -$39.25 M -$23.85 M -$10.25 M -$9.22 M
Income Before Tax Ratio -11.95 -308.02 -16.62 -35.7 0 0
Income Tax Expense $1.60 K -$12.26 M $1.57 M -$278.00 K $1.01 M $281.00 K
Net Income -$131.07 K -$98.57 M -$39.25 M -$23.85 M -$10.25 M -$9.22 M
Net Income Ratio -12.1 -308.02 -16.62 -35.7 0 0
EPS -0.0045 -3.39 -1.43 -4.49 -0.91 -0.74
EPS Diluted -0.0045 -3.39 -1.43 -4.49 -0.91 -0.74
Weighted Average Shares Out $29.40 M $29.06 M $27.49 M $5.31 M $11.25 M $12.39 M
Weighted Average Shares Out Diluted $29.40 M $29.06 M $27.49 M $5.31 M $11.25 M $12.39 M
Link